NOVARTIS Financials

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NI</div>
NOVARTIND -- India Stock  

INR 587.90  5.20  0.89%

Understanding current and past NOVARTIS INDIA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We recommend to make use of NOVARTIS INDIA LTD fundamental analysis to see if markets are currently mispricing the entity. Strictly speaking, this interface allows you to check out available financial ratios of NOVARTIS INDIA LTD as well as the relationship between them. We found twenty-eight available fundamentals for NOVARTIS INDIA, which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all NOVARTIS INDIA LTD financials, including its Cash per Share as well as the relationship between Cash Flow from Operations and Z Score . Use NOVARTIS INDIA to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of NOVARTIS INDIA to be traded at 646.69 in 30 days.

Search Fundamentals

 
Refresh
With this module, you can analyze NOVARTIS financials for your investing period. You should be able to track the changes in NOVARTIS INDIA individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
24%24%

Chance of Financial Distress

NOVARTIS INDIA LTD has less than 24 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of ods of distress for NOVARTIS INDIA stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

NOVARTIS INDIA Company Summary

Novartis India Limited primarily trades in drugs and pharmaceuticals. The company was incorporated in 1947 and is headquartered in Mumbai, India. NOVARTIS INDIA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on Bombay Stock Exchange. It employs 581 people.
InstrumentIndia Stock View All
ExchangeBombay Stock Exchange
Business AddressInspire BKC, G
SectorHealthcare
IndustryDrug Manufacturers?Specialty & Generic
BenchmarkDOW
Websitewww.novartis.in
Phone91 22 5024 3000
CurrencyINR

NOVARTIS INDIA Key Financial Ratios

NOVARTIS Financial Ratios Relationships

NOVARTIS INDIA LTD is considered to be number one stock in net income category among related companies. It is considered to be number one stock in cash per share category among related companies . The ratio of Net Income to Cash per Share for NOVARTIS INDIA LTD is about  868,325 

NOVARTIS INDIA LTD Systematic Risk

The output start index for this execution was twenty-two with a total number of output elements of thirty-nine. The Beta measures systematic risk based on how returns on NOVARTIS INDIA LTD correlated with the market. If Beta is less than 0 NOVARTIS INDIA generally moves in the opposite direction as compared to the market. If NOVARTIS INDIA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NOVARTIS INDIA LTD is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NOVARTIS INDIA is generally in the same direction as the market. If Beta > 1 NOVARTIS INDIA moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About NOVARTIS INDIA Financials

What exactly are NOVARTIS INDIA Financials? Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include NOVARTIS INDIA income statement, its balance sheet, and the statement of cash flows. Potential NOVARTIS INDIA investors and stakeholders use the financial statements to determine how well the company is positioned to perform in the future. Although NOVARTIS INDIA investors may use each financial statement separately, they are all related. The changes in NOVARTIS INDIA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NOVARTIS INDIA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Novartis India Limited primarily trades in drugs and pharmaceuticals. The company was incorporated in 1947 and is headquartered in Mumbai, India. NOVARTIS INDIA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on Bombay Stock Exchange. It employs 581 people.

NOVARTIS INDIA June 4, 2020 Opportunity Range

Additionally, see Stocks Correlation. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page